The U.S. Food and Drug Administration’s January 5 decision to allow Florida to import prescription drugs from Canada opens the door for other states to increase supply in their markets and reduce costs for consumers as political pressure on the pharmaceutical industry builds.
But some lawmakers are also eyeing the groups that often help broker deals between pharmacies, drug companies, and health insurers: pharmacy benefit managers (PBMs).
Want to see more of The Dispatch in Google search?
Add Us as a Preferred Source



